InflaRx N.V. Files 6-K for Share Offering
Ticker: IFRX · Form: 6-K · Filed: Feb 18, 2025 · CIK: 1708688
Sentiment: neutral
Topics: equity-offering, underwriting, capital-raise
Related Tickers: INFX
TL;DR
INFX raising cash via share offering, details in 6-K.
AI Summary
On February 13, 2025, InflaRx N.V. entered into an Underwriting Agreement with Guggenheim Securities, LLC, as representative of the underwriters, for an offering of 8,250,000 ordinary shares with a nominal value of €0.12 per share.
Why It Matters
This filing indicates InflaRx N.V. is raising capital through the sale of its ordinary shares, which could fund ongoing operations or future development.
Risk Assessment
Risk Level: medium — Share offerings can dilute existing shareholders and signal a need for capital, but also provide funds for growth.
Key Numbers
- 8,250,000 — Ordinary Shares Offered (This is the total number of shares InflaRx N.V. is offering to the public.)
- €0.12 — Nominal Value per Share (This is the stated nominal value of each ordinary share being offered.)
Key Players & Entities
- InflaRx N.V. (company) — Registrant
- Guggenheim Securities, LLC (company) — Underwriter Representative
- February 13, 2025 (date) — Date of Underwriting Agreement
- 8,250,000 (dollar_amount) — Number of ordinary shares offered
- €0.12 (dollar_amount) — Nominal value per ordinary share
FAQ
What is the total number of ordinary shares being offered by InflaRx N.V.?
InflaRx N.V. is offering an aggregate of 8,250,000 ordinary shares.
Who is acting as the representative for the underwriters in this offering?
Guggenheim Securities, LLC is acting as the representative for the underwriters.
On what date did InflaRx N.V. enter into the Underwriting Agreement?
The Underwriting Agreement was entered into on February 13, 2025.
What is the nominal value of each ordinary share being offered?
The nominal value per ordinary share is €0.12.
Is InflaRx N.V. required to file annual reports under Form 20-F or Form 40-F?
InflaRx N.V. indicates it files annual reports under Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on February 18, 2025 regarding InflaRx N.V. (IFRX).